Caley Castelein - Net Worth and Insider Trading
Caley Castelein Net Worth
The estimated net worth of Caley Castelein is at least $14 Million dollars as of 2024-06-07. Caley Castelein is the Director of Tourmaline Bio Inc and owns about 974,558 shares of Tourmaline Bio Inc (TRML) stock worth over $13 Million. Caley Castelein is the Director of Aadi Bioscience Inc and owns about 279,692 shares of Aadi Bioscience Inc (AADI) stock worth over $495,055. Caley Castelein is also the Director of ViewRay Inc and owns about 99,047 shares of ViewRay Inc (VRAYQ) stock worth over $1. Details can be seen in Caley Castelein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Caley Castelein has not made any transactions after 2023-10-27 and currently still holds the listed stock(s).
Transaction Summary of Caley Castelein
Caley Castelein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Caley Castelein owns 5 companies in total, including Aerpio Pharmaceuticals Inc (ARPO) , ViewRay Inc (VRAYQ) , and Neos Therapeutics Inc (NEOS) among others .
Click here to see the complete history of Caley Castelein’s form 4 insider trades.
Insider Ownership Summary of Caley Castelein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARPO | Aerpio Pharmaceuticals Inc | 2020-06-24 | director |
| VRAYQ | ViewRay Inc | 2023-07-19 | director |
| NEOS | Neos Therapeutics Inc | 2015-07-28 | 10 percent owner |
 | | 2021-08-26 | director |
| | 2023-10-19 | director |
Caley Castelein Latest Holdings Summary
Caley Castelein currently owns a total of 3 stocks. Among these stocks, Caley Castelein owns 974,558 shares of Tourmaline Bio Inc (TRML) as of October 27, 2023, with a value of $13 Million and a weighting of 96.39%. Caley Castelein owns 279,692 shares of Aadi Bioscience Inc (AADI) as of August 26, 2021, with a value of $495,055 and a weighting of 3.61%. Caley Castelein also owns 99,047 shares of ViewRay Inc (VRAYQ) as of July 19, 2023, with a value of $1 and a weighting of 0%.
Latest Holdings of Caley Castelein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRML | Tourmaline Bio Inc | 2023-10-27 | 974,558 | 13.56 | 13,215,006 |
| AADI | Aadi Bioscience Inc | 2021-08-26 | 279,692 | 1.77 | 495,055 |
| VRAYQ | ViewRay Inc | 2023-07-19 | 99,047 | 0.00 | 1 |
Holding Weightings of Caley Castelein
Caley Castelein Form 4 Trading Tracker
According to the SEC Form 4 filings, Caley Castelein has made a total of 1 transactions in Tourmaline Bio Inc (TRML) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tourmaline Bio Inc is the acquisition of 20,000 shares on October 27, 2023, which cost Caley Castelein around $280,600.
According to the SEC Form 4 filings, Caley Castelein has made a total of 1 transactions in Aadi Bioscience Inc (AADI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aadi Bioscience Inc is the acquisition of 259,998 shares on August 26, 2021, which cost Caley Castelein around $3 Million.
According to the SEC Form 4 filings, Caley Castelein has made a total of 2 transactions in ViewRay Inc (VRAYQ) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in ViewRay Inc is the sale of 2,345,030 shares on July 19, 2023, which brought Caley Castelein around $140,702.
Insider Trading History of Caley Castelein
- 1
Caley Castelein Trading Performance
GuruFocus tracks the stock performance after each of Caley Castelein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Caley Castelein is 103.96%. GuruFocus also compares Caley Castelein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Caley Castelein within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Caley Castelein's insider trading performs compared to the benchmark.
Performance of Caley Castelein
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 25.3 | | | | | |
| Relative Return to S&P 500(%) | 20.47 | | | | | |
Caley Castelein Ownership Network
Caley Castelein Owned Company Details
What does Aerpio Pharmaceuticals Inc do?
Who are the key executives at Aerpio Pharmaceuticals Inc?
Caley Castelein is the director of Aerpio Pharmaceuticals Inc. Other key executives at Aerpio Pharmaceuticals Inc include director & 10 percent owner Orbimed Advisors Llc , Vice President of Finance Regina Marek , and director & President Joseph H. Gardner .
Aerpio Pharmaceuticals Inc (ARPO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aerpio Pharmaceuticals Inc (ARPO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerpio Pharmaceuticals Inc (ARPO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aerpio Pharmaceuticals Inc (ARPO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerpio Pharmaceuticals Inc Insider Transactions
Caley Castelein Mailing Address
Above is the net worth, insider trading, and ownership report for Caley Castelein. You might contact Caley Castelein via mailing address: Thom. Weisel Healthcare Ventures, One Montgomery Street, San Francisco Ca 94104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
